These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9163021)

  • 1. Herpesviruses and AIDS.
    Griffiths PD
    Scand J Infect Dis Suppl; 1996; 100():3-7. PubMed ID: 9163021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New developments with herpesviruses and the nervous system.
    Picard FJ; Poland SD; Rice GP
    Curr Opin Neurol Neurosurg; 1993 Apr; 6(2):169-75. PubMed ID: 8386954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of the interactions between herpes simplex viruses and HIV-1.
    Palù G; Benetti L; Calistri A
    Herpes; 2001 Jul; 8(2):50-5. PubMed ID: 11867019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention and treatment of VZV infections in patients with HIV.
    Gershon AA
    Herpes; 2001 Jul; 8(2):32-6. PubMed ID: 11867015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: baseline CMV load dictates time to disease and survival. The AIDS Clinical Trials Group 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group.
    Emery VC; Sabin C; Feinberg JE; Grywacz M; Knight S; Griffiths PD
    J Infect Dis; 1999 Sep; 180(3):695-701. PubMed ID: 10438356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
    Zuckerman RA; Lucchetti A; Whittington WL; Sanchez J; Coombs RW; Zuñiga R; Magaret AS; Wald A; Corey L; Celum C
    J Infect Dis; 2007 Nov; 196(10):1500-8. PubMed ID: 18008230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.
    Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A
    Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression.
    Schacker T; Zeh J; Hu H; Shaughnessy M; Corey L
    J Infect Dis; 2002 Dec; 186(12):1718-25. PubMed ID: 12447756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [AIDS and opportunistic virus infections].
    Sugiura M; Matsuura A; Imai S; Sakurada K; Miyazaki T; Osato T
    Hokkaido Igaku Zasshi; 1993 Sep; 68(5):609-11. PubMed ID: 8225165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic antivirals for therapy of herpesvirus diseases.
    Merigan TC
    Dev Biol Stand; 1982; 52():527-33. PubMed ID: 6187616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of genital herpes in HIV-infected patients.
    Aoki FY
    Herpes; 2001 Jul; 8(2):41-5. PubMed ID: 11867017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpesviruses and AIDS.
    Griffiths PD
    J Antimicrob Chemother; 1996 May; 37 Suppl B():87-95. PubMed ID: 8818832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tomorrow's challenges for herpesvirus management: potential applications of valacyclovir.
    Griffiths PD
    J Infect Dis; 2002 Oct; 186 Suppl 1():S131-7. PubMed ID: 12353198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged herpes zoster in a patient infected with the human immunodeficiency virus.
    Matsuo K; Honda M; Shiraki K; Niimura M
    J Dermatol; 2001 Dec; 28(12):728-33. PubMed ID: 11804069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HSV-2 and HIV: consequences of an endemic opportunistic infection.
    Wald A; Schacker T; Corey L
    STEP Perspect; 1997; 9(3):2-4. PubMed ID: 11364936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV infection and AIDS.
    Lloyd A
    P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral participation in cellular and microenvironmental transformation and amplification towards malignancy in AIDS patients.
    Agius LM
    Med Hypotheses; 2004; 62(4):593-9. PubMed ID: 15050113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of nested PCR and real time PCR of Herpesvirus infections of central nervous system in HIV patients.
    Drago L; Lombardi A; De Vecchi E; Giuliani G; Bartolone R; Gismondo MR
    BMC Infect Dis; 2004 Nov; 4():55. PubMed ID: 15571633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-lymphocytopaenia, opportunistic infections and pathological findings in Ghanaian AIDS patients and their sexual partners.
    Ayisi NK; Wiredu EK; Sata T; Nyadedzor C; Tsiagbe VK; Newman M; Cofie CN; Taneguchi K
    East Afr Med J; 1997 Dec; 74(12):784-91. PubMed ID: 9557423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fulminant varicella hepatitis in a human immunodeficiency virus infected patient: case report and review of the literature.
    Lechiche C; Le Moing V; François Perrigault P; Reynes J
    Scand J Infect Dis; 2006; 38(10):929-31. PubMed ID: 17008242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.